Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02603445
Title Study of Safety and Efficacy of BCL201 and Idelalisib in Patients With FL and MCL
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | FRA | DEU | AUT

Facility Status City State Zip Country Details
Novartis Investigative Site New York New York 10017 United States Details
Novartis Investigative Site Houston Texas 77030 United States Details
Novartis Investigative Site Salzburg 5020 Austria Details
Novartis Investigative Site Pierre Benite Cedex 69495 France Details
Novartis Investigative Site Toulouse Cedex 9 31059 France Details
Novartis Investigative Site Freiburg 79106 Germany Details
Novartis Investigative Site Mainz 55131 Germany Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field